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MitochondriaPostconditioning (PostC) may limit mitochondrial damage and apoptotic signaling. We studied markers of
apoptosis andmitochondrial protection in isolated rat hearts, which underwent a) perfusionwithout ischemia
(Sham), b) 30-min ischemia (I) plus 2-hour reperfusion (R), or c) PostC protocol (5 intermittent cycles of 10-s
reperfusion and 10-s ischemia immediately after the 30-min ischemia). Markers were studied in cytosolic (CF)
and/or mitochondrial (MF) fractions. In CF, while pro-apoptotic factors (cytochrome c and caspase-3) were
reduced, the anti-apoptotic markers (Bcl-2 and Pim-1) were increased by PostC, compared to the I/R group.
Accordingly, phospho-GSK-3β and Bcl-2 levels increased inmitochondria of PostC group.Moreover, I/R reduced
the level ofmitochondrial structural protein (HSP-60) inMFand increased in CF, thus suggestingmitochondrial
damage andHSP-60 release in cytosol,whichwere prevented by PostC. Electronmicroscopyconﬁrmed that I/R
markedly damaged cristae and mitochondrial membranes; damage was markedly reduced by PostC. Finally,
total connexin-43 (Cx43) levels were reduced in the CF of the I/R group, whereas phospho-Cx43 level resulted
in higher levels in the MF of the I/R group than the Sham group. PostC limited the I/R-induced increase of
mitochondrial phospho-Cx43. Data suggest that PostC i) increases the levels of anti-apoptotic markers,
including the cardioprotective kinase Pim-1, ii) decreases the pro-apoptotic markers, e.g. cytochrome c, iii)
preserves the mitochondrial structure, and iv) limits the migration of phospho-Cx43 to mitochondria.© 2009 Elsevier B.V. All rights reserved.1. Introduction
Cycles of brief reperfusion and ischemia performed immediately at
the onset of reperfusion following a prolonged ischemic insult
markedly limits reperfusion injury [1–11]. Zhao et al. [1] named this
cardioprotective phenomenon “postconditioning” (PostC), which is as
powerful as ischemic preconditioning [1–11]. It seems that in rodents
PostC protection requires the involvement of several kinases of the
reperfusion injury salvage kinase (RISK) pathway, including ERK1/2,
phosphatidylinositol 3-kinase (PI3K), protein kinase B (PKB/Akt),
protein kinase C (PKC) and glycogen synthase kinase (GSK-3β), as
well as nitric oxide synthase (NOS) and guanylyl-cyclase [2–11].
Recently, it has been suggested that PostC attenuates lethal reperfu-
sion injury via the opening of mitochondrial KATP channels (mKATP)
and ROS-signaling, which may lead to a reduction of mitochondrial
calcium accumulation, and inhibition of mitochondrial permeability
transition pore (mPTP) opening [6,10,11]. Inhibition of mPTP openingniche e Biologiche, Università
le, 10, 10043 Orbassano (TO),
ll rights reserved.[7,10] is reported to be a critical end-effector of the cardioprotective
effects of PostC. Therefore mitochondria may play a central role in
PostC cardioprotection. Yet, Heusch's group reported that mitochon-
drial connexin 43 (Cx43) may play a pivotal role in preconditioning,
though cardioprotection by postconditioning in Cx43-deﬁcient mice is
not lost [12,13]. Nevertheless, Cx43 may play an important role in
mitochondrial ROS signaling [12,13].
PostC may limit all forms of cell death (apoptosis, autophagy and
necrosis) induced by I/R [14–16]. Apoptosis in reperfusion injury is
minor compared to necrosis as indicated by the reduced markers of
necrosis (enzyme release and infarct size) in a PostC scenario
[1,3,5,6,8,9]. However, apoptosis is an important cause of cell death
in the ischemia/reperfusion, via both the extrinsic and the intrinsic
pathways, which may be accelerated by the bursts of free radicals
occurring in reperfusion [14–18]. Therefore reperfusionmay represent
the principal moment inwhich apoptosis is present. Since, a cell dying
by necrosis may initially show some features of apoptosis, and since
both death forms involve mitochondria integrity [14–18], it is
important to correlate markers of apoptosis with mitochondria
integrity in early reperfusion protection by PostC.
Recently, in a study conducted on isolated cardiac cells it has been
reported that protection by PostC against apoptosis is mediated by
reduced generation of superoxide anions, lowered activity of JNKs/
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by the modulation of Bax/Bcl-2 ratio [17].
Both in pre- and post-conditioning, PI3K activation is considered
an initial step that induces phosphorylation of downstream kinases,
which inhibit several pro-apoptotic factors and the mPTP opening at
reperfusion [7,18,19]. However, in these protective pathways the anti-
apoptotic activity of the cytoplasmic serine/threonine kinase Pim-1
has not been considered, yet. Pim-1 is downstream in the JAK/STAT
pathway and plays a crucial role in cardioprotection downstream to
Akt [20–23]. Yet, Pim-1 has been reported to have anti-apoptotic
activity in myeloid cells and it is considered to be an upstream
regulator of bcl-2 expression [21,22]. These data suggest that Pim-1
might also be downstream to PI3K. However, no studies have tested
the involvement of Pim-1 in postconditioning. Since the PI3K
antagonist(s) may directly interfere with Pim-1 activity [20,23], it is
necessary to ascertain with a direct method whether or not Pim-1 is
involved in PostC. Moreover, markers of mitochondrial integrity (e.g.
Heat Shock Protein-60, HSP-60) are not extensively investigated.
Therefore, the principal goal of the present study is to determine
whether or not PostC affects markers of mitochondrial integrity and
correlated apoptotic factors. In particular, using western blot analysis,
we studied, in both cytosol and mitochondria isolated from isolated rat
heart, whether or not the PostC protocol affected the levels of pro-
apoptotic cytochrome c and caspase-3 as well as protective kinases such
as Bcl-2, novel Pim-1 and phospho-GSK-3β. Moreover, we studied the
level and the status of phosphorylation/dephosphorylation of an
important component of the inner mitochondrial membrane (i.e.
Cx43) both in mitochondrial and cytosolic fractions. Finally, the
preservation of the integrity of mitochondria was evaluated by
measuring cytosolic levels ofHSP-60,while theultrastructure of isolated
mitochondria was visualized using electron-microscopy imaging.
2. Materials and methods
2.1. Animals
Male Wistar rats (450–550 g) were treated according to NIH
Publication (No. 85-23, revised 1996), and the Italian law.
2.2. Perfusion technique
Methods used were similar to those previously described [5,6,24].
In brief, isolated rat hearts were retrogradely perfused with
oxygenated Krebs–Henseleit buffer at constant ﬂow (9±1 ml/min/
g) [5,6,24], paced at 280 bpm and kept in a temperature-controlled
chamber (37 °C). Coronary perfusion pressure and left ventricular
pressure were monitored to assess the preparation conditions.
2.3. Experimental protocols
After the stabilization period, hearts were randomly divided in
three groups: i) Sham group (no-ischemia; n=6), hearts underwent
150-min buffer-perfusion only; ii) I/R group (n=6), hearts under-
went 30-min of global-ischemia and then a period of 120-min full-
reperfusion; iii) PostC group (n=6), after the 30-min ischemia, hearts
underwent a PostC protocol. This consisted of 5 cycles of 10-s
reperfusion and 10-s global ischemia and then heart completed the
120-min full-reperfusion [5,6,24].
2.4. Isolation of rat heart mitochondria
Mitochondrial and cytosolic fractions were obtained by a mod-
iﬁcation of published procedures [10,25–27]. The left ventricle was
quickly submerged in 250 mM mannitol, 0.5 mM EGTA, 5 mM Hepes,
and 0.1% (w/v) BSA (pH 7.4). The tissue was ﬁnely minced with
scissors and then homogenized in the same buffer (10 ml buffer per gtissue), using an ice-cold Potter. Large cell debris (membrane and
nuclear fractions) were pelleted by centrifuging the homogenate
twice for 5 min at 600 g and discarded avoiding solubilization of
membrane proteins. Mitochondria were pelleted by 10 min centrifu-
gation at 10,300 g. The supernatant was centrifuged for 1 h at
100,000 g to obtain cytosolic fraction. The mitochondrial pellet was
suspended, loaded in tubes containing 30% (v/v) Percoll in 225 mM
mannitol, 1 mM EGTA, 25 mM Hepes, 0.1% (w/v) BSA (pH 7.4) and
spun for 30 min at 95,000 g in a Beckman SW40 rotor. Mitochondria
were collected from the lower part of the dense, brownish yellow
mitochondrial band. Protein level in each fraction was determined by
Bradford's method [28].
2.5. Electron microscopy
To conﬁrm the integrity and purity of mitochondrial fractions,
electron microscopy was used [10,27]. Data were also used for a semi-
quantitative analysis. The mitochondrial pellet was ﬁxed in 2.5%
glutaraldehyde (Fluka, St Louis, MO, USA) and 0.5% saccharose in 0.1M
Sörensen phosphate buffer (pH 7.2) for 2 h. The pellet was then
washed in 1.5% saccharose in 0.1 M Sörensen phosphate buffer (pH
7.2) for 6–12 h, post-ﬁxed in 2% osmium tetroxide, dehydrated and
embedded in Glauert's embedding mixture, which consists of equal
parts of Araldite M and Araldite Härter, HY 964 (Merck), supplemen-
ted with 2% of the accelerator DY 064 (Merck). A plasticizer, dibutyl
phthalate, was added at 0.5%. Thin sections (70 nm) were cut using a
Leica Ultracut UCT, stained with uranyl acetate and lead citrate, and
examined in a JEM-1010 transmission electron microscope (JEOL,
Tokyo, Japan) equipped with a Mega-View-III digital camera and a
Soft-Imaging-System (SIS, Münster, Germany) for computerized
acquisition of images.
2.6. Western blotting
About 50 μg of protein extracts were separated by SDS-PAGE on
10% (for HSP-60, connexin-43, phospho-connexin-43, GSK-3β,
phospho-GSK-3β, caspase-3, Pim-1) or 12% (for cytochrome c and
Bcl-2) gels and transferred to PVDF membrane (GE-Healthcare).
The membranes were incubated overnight with the following primary
antibodies: anti-HSP-60 (BD Biosciences), anti-connexin-43 (Sigma),
anti-phospho-(Ser-368)-connexin-43, anti-GSK-3β, anti-phospho-
(Ser-9)-GSK-3β, anti-caspase-3 (cleaved form), anti-Pim-1, anti-Bcl-2
(Cell Signaling), and anti-cytochrome c (BD-Pharmingen), all were
diluted according to the manufacturer's instructions. Immunoblotted
proteins were visualized by using Immuno-Star HRP Substrate Kit
(BioRad) and quantiﬁed by Kodak Image Station 440CF. To conﬁrm
equal protein loading, blots were stripped with 0.4 M NaOH and then
re-blotted with an anti-α-actin antibody (Sigma) for both cytosolic
and mitochondrial fractions. Image analyses were performed by the
Kodak 1D 3.5 software.
2.7. Statistical analysis
All values are expressed as mean±SE. Data were analyzed using
one-way analysis of variance (ANOVA) followed by Bonferroni's post
test. p Value≤0.05 was considered to be signiﬁcant.
3. Results
We studied anti- and pro-apoptosis markers as well as constitutive
mitochondrial components in three groups of isolated rat hearts,
which underwent i) buffer-perfusion without ischemia (Sham), ii)
30-min ischemia plus 2-hour reperfusion (I/R), or iii) PostC protocol
immediately after the 30-min ischemia, i.e. at the onset of reperfusion.
Marker/protein levels were studied by Western-blot analysis in
cytosolic and/or mitochondrial fractions.
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As shown in Fig. 1A, in cytosolic fraction, the anti-apoptotic Bcl-2
protein levels were higher in Sham and PostC, than I/R group
(26.35±0.13 and 23.95±0.25 vs 5.64±0.07 arbitrary units). Also, in
mitochondrial fraction, Bcl-2 protein levels were higher in Sham and
PostC, than I/R group (15.90±1.80 and 23.23±1.37 vs 11.23±2.78
arbitrary units). As shown in Fig. 1B, in cytosolic fraction, the level of
protective Pim-1 was also signiﬁcantly reduced in I/R group with
respect to Sham and PostC groups (20.02±0.20 vs 35.02±0.13 and
28.84±0.31 arbitrary units). Yet, inmitochondrial fraction Pim-1wereFig. 1. Expression of anti-apoptotic factors in the three experimental groups (Sham,
Ischemia/reperfusion (I/R), and Postconditioned groups (PostC); n=6 each). Panel A
and Panel B represent, respectively, Bcl-2 and Pim-1 expression in the cytosolic (CF) or
mitochondrial fraction (MF). Data are expressed in arbitrary units and normalized for
loading control (α-Actin). Panel C shows representative blots. ⁎=pb0.05 vs Sham;
#=pb0.05 vs I/R.
Fig. 2. Expression of GSK-3β in the three experimental groups (Sham, Ischemia/
reperfusion (I/R), and Postconditioned groups (PostC). Panel A, represents total GSK-3β
in the cytosolic fraction (CF) and Panel B, represents the expression of the
phosphorylated/inhibited form (phospho-GSK-3β) in the mitochondrial fraction
(MF). Data are expressed in arbitrary units and normalized for loading control (α-
Actin). Panel C shows representative blots. ⁎=pb0.05 vs Sham; #=pb0.05 vs I/R.extremely low in the three experimental conditions. These results
suggest that PostC treatments attenuate Bcl-2 and Pim-1 reduction at
cytosolic levels, while increasing Bcl-2 mitochondrial levels, thus
protecting the heart from I/R induced apoptosis. These results are also
in line with those suggesting that Pim-1 acts at cytoplasmatic and
nuclear level both as upstream regulator of bcl-2 expression and as a
survival factor to inhibit apoptosis and necrosis [18,22,29].
GSK-3β is a kinase normally expressed in the cytosol of the cells,
which is protective when it is inhibited by phosphorylation in
serine-9. In fact, the phospho-GSK-3β/total-GSK-3β ratio increases
from 0.56±0.02 in Sham to 0.74±0.007 (pb0.05) in PostC groups.
Since, it has been suggested that phospho-GSK-3β is translocated to
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in reperfusion [30–32], we checked GSK-3β in bothmitochondrial and
cytosolic fractions. As shown in Fig. 2A, while in cytosolic fraction,
total GSK-3β level was higher in the I/R group than the other two
groups (10.29±0.80 vs 4.58±0.12 and 4.50±0.14 arbitrary units), in
the mitochondrial fraction total GSK-3β was more expressed in
Sham and PostC groups compared to the I/R group (12.02±0.11 and
10.65±0.14 vs 6.54±0.81 arbitrary units). As shown, in Fig. 2B,
phospho-GSK-3β, in the mitochondrial fraction, was higher in the
PostC group with respect to the Sham and I/R groups (5.98±0.10 vs
4.72±0.13 and 4.50±0.12 arbitrary units). Yet, in the cytosolic
fraction the phospho-GSK-3β level was similar in all three experi-
mental groups.
Data are in agreement with the idea that by enhancing mitochon-
drial GSK-3β phosphorylation/inactivation in reperfusion phase,
PostC may limit mPTP opening and cell death [18,33].
3.2. Factors of the mitochondrial apoptotic death pathway
We studied the cytosolic levels of two important factors of the
mitochondrial apoptotic death pathway, i.e. the pro-apoptotic cyto-
chrome c and cleaved caspase-3 cytosolic protein levels [14]. As shownFig. 3. Expression of pro-apoptotic factors in the three experimental groups (Sham,
Ischemia/reperfusion (I/R), and Postconditioned groups (PostC); n=6 each). Panel A
and Panel B represent, respectively, cytochrome c and cleaved caspase-3 in cytosolic
fraction (CF). Panel C shows representative blots.
Fig. 4. Expression of mitochondrial constitutive protein HSP-60 in the three
experimental groups (Sham, Ischemia/reperfusion (I/R), and Postconditioned groups
(PostC); n=6 each). HSP-60 data are from cytosolic (CF) and mitochondrial (MF)
fractions. Data are expressed in arbitrary units and normalized for loading control (α-
Actin). Panel B shows representative blots. ⁎=pb0.05 vs Sham; #, pb0.05 vs I/R.in Fig. 3A, in cytosolic fractions cytochrome c level was higher in the I/
R group (7.16±0.19 arbitrary units) than in Sham and PostC groups
(2.96±0.12 and 3.25±0.12 arbitrary units). Data suggest that
ischemia/reperfusion promotes the release of cytochrome c from
mitochondria to cytosol and that PostC prevents this release. In line
with these results, we found that cleaved caspase-3 cytosolic protein
levels (Fig. 3B) were lower in Sham and PostC groups compared to the
I/R group (5.24±0.08 and 5.27±0.10 vs 18.45±0.16 arbitrary units).
3.3. Mitochondrial constitutive proteins
Heat shock protein-60 (HSP-60) and connexin-43 (Cx43) were
studied both in mitochondrial and cytosolic fractions. HSP-60 is an
important constitutive protein of mitochondria [34].
As shown in Fig. 4, in the mitochondrial fraction of Sham hearts,
HSP-60 level was 33.8±0.58 arbitrary units. HSP level was reduced to
1.6±0.04 in hearts subjected to I/R. The PostC has avoided the
reduction in the levels of HSP-60, which were found to be 27.9±0.4
arbitrary units. Data suggest that, in the mitochondria isolated from
the I/R group, the level of this protein was almost absent because the
integrity of mitochondrial membranes was lost. Yet, the level of HSP-
60 in the PostC group was markedly higher than that observed in the
I/R group and only slightly lower than that observed in the Sham
group; thus suggesting mitochondrial ultra-structure preservation by
PostC. In fact, in the analysis of cytosolic extracts HSP-60 level was
higher in the I/R group with respect to Sham and PostC (13.14±0.79
vs 1.25±0.09 and 1.27±0.09 arbitrary units); thus conﬁrming the
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mitochondria of PostC group.
Connexin-43 is a member of the family of structurally-related
transmembrane proteins, whose phosphorylated portion (phospho-
Cx43) increases with ischemia [35] similarly to p53 [36]. In fact, as
shown in Fig 5B, in the mitochondrial fraction phospho-Cx43 level
was higher in the I/R groupwith respect to Sham group (7.84±0.13 vs
0.71±0.19 arbitrary units). PostC treatment limited the increase ofFig. 5. Expression of mitochondrial constitutive protein connexin-43 in the three
experimental groups (Sham, Ischemia/reperfusion (I/R), and Postconditioned groups
(PostC); n=6 each). Connexin-43 data are from cytosolic (CF) and mitochondrial (MF)
fractions. Panel A, phospho-connexin-43; Panel B, total connexin-43. InMF connexin-43
is detected mainly in the phosphorylated (phospho-connexin-43) form only in heart
subjected to I/R with or without PostC. Data are expressed in arbitrary units and
normalized for loading control (α-Actin). Panel C shows representative blots.
⁎=pb0.05 vs Sham; #, pb0.05 vs I/R.phospho-Cx43 to 5.55±0.21 (arbitrary units). In the cytosolic
fractions of the three groups there were very low levels of phospho-
Cx43, which were not inﬂuenced by experimental maneuvers.
Yet, as shown in Fig. 5A, total Cx43 level was higher in the cytosolic
fraction of Sham than that of the I/R group (24.00±0.03 vs 19.33±
0.19 arbitrary units). PostC protocol avoided the reduction in total
Cx43 cytosolic level, which showed similar results to that of the Sham
group (28.33±0.19 and 24.00±0.03 arbitrary units). Mitochondrial
fraction levels of total Cx43 were also similar in the Sham and the
PostC groups (17.01±0.30 and 19.21±0.20 arbitrary units), while I/R
protocol induced an increase of its level (26.12±0.19 arbitrary units).
Data suggests that PostC limits the phosphorylation and transloca-
tion of Cx43 to the mitochondria that occurs in I/R. It is likely that
ischemia induces an internalization of gap junctional Cx43 and that
the cytosolic Cx43 content will be inﬂuenced by changes of Cx43 at the
gap junctions and of phospho-Cx43 at the mitochondrial level.
However, this needs to be ascertained in a future study.
3.4. Electron microscopy
As can be seen in Panels A and B (Control/Sham), and Panels C and
D (I/R) of Fig. 6, electron microscopy of isolated mitochondria
conﬁrmed that I/R induced marked damage to mitochondrial
membranes with cristae disaggregation. In fact the presence of
electron dense mitochondrial cristae and well-deﬁned membranes
can be observed in about 90% of normal mitochondria, the small
percentage of structural disorganization being attributable to the
process of mitochondrial extraction. By contrast, I/R caused structural
damage in about 80% of mitochondria. Mitochondrial damage can be
recognized by the reduced electrondensity of the cristae, presence of
broken cristae, andmitochondrial membrane disruption (Panels C, D).
The presence of these signs of mitochondrial disorganization was
reduced by PostCwhere the percentage of damagedmitochondriawas
around 50% (Fig. 6, Panels E, F).
Overall data suggest that mitochondrial protection and anti-
apoptotic effects are central aspects of PostC protection. Protective
kinases (i.e. Pim-1 and phospho-GSK-3β) may play a pivotal role in
these protective mechanisms.
4. Discussion
This study indicates that cardioprotection triggered by PostC
depends on the activation/inhibition and/or changes in the level of
different kinases related to mitochondria integrity. In fact, PostC
enhances phosphorylation/inactivation of mitochondrial GSK-3β.
These effects are accompanied by a reduction of cytochrome c release
from mitochondria and a reduction of cleaved caspase-3 cytosolic
level. Our data also suggest that PostC-induced cardioprotection is
characterized by an attenuation of the reduction of the cytosolic levels
of Bcl-2 and Pim-1 in the post-ischemic phase. Moreover, PostC
mitochondria express more Bcl-2 and less phospho-Cx43 than hearts
subjected only to I/R. In the postconditioned hearts mitochondria are
less damaged as suggested by the electron microscopy analysis and
the preserved level of mitochondrial HSP-60.
Myocardial I/R injury results in robust appearance of cardiomyo-
cyte apoptosis, which contributes to infarct size and long term
ventricular dysfunction. The present study considers both in the
cytosol and isolated mitochondria fractions of isolated hearts the
regulation of several pro- and anti-apoptotic factors together with
ultra-structural changes induced by I/R and PostC.
It has been reported in a cardiomyocyte-like cell line that PostC
reduces apoptosis and that the over-expression of Bcl-2 protects these
cells from apoptosis [17,37]. In fact, Bcl-2 proteins attenuate p53-
mediated apoptosis in cardiomyocytes [38], increase the Ca2+
threshold for mitochondrial transition pore opening, decrease
mitochondrial Ca2+ efﬂux due to Na+-dependent Ca2+ exchanger in
Fig. 6. Electronmicrographs of isolatedmitochondria from Control/Sham group (A, B), I/R group (C, D) and PostC group (E, F). Electronmicroscopy conﬁrmed the integrity and purity
of mitochondrial fraction before I/R. While in normal mitochondria (Panels A, B) well-deﬁned membranes and cristae can be observed, as expected, I/R caused mitochondrial
damage mainly characterized by extended disruption of mitochondrial membranes and the abundant presence of broken cristae (Panels C, D). The clear reduction in electrondensity
of mitochondrial cristae observable in I/R samples is another sign of mitochondrial damage. On the other hand, all ultrastructural signs of mitochondrial damage were drastically
reduced by PostC (Panels E, F).
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sis in isolated adult cardiomyocytes [40]. Importantly, the increase of
Bcl-2 may reduce necrotic and oncotic death [18].
Here we conﬁrm, in an isolated rat heart model, that PostC avoids
Bcl-2 reduction, which usually accompanies I/R; thus conﬁrming that
the anti-apoptotic effect of PostC involves this factor in organ
preparation. Our results are in line with the reported anti-apoptotic
effect associated with the retention of Ca2+ within mitochondria in
postconditioned heart [10]; in fact the high level of Bcl-2 may sustain
mitochondrial Ca2+ retention.
Here we present, for the ﬁrst time, a role for Pim-1 during PostC
protocol. The activation of PI3K/Akt during the PostC protocol has
been reported by different groups [2,8,41]. Pim-1 operates down-
stream of Akt, and a feedback mechanism exists involving the two
proteins. Pim-1 inactivation may increase apoptotic activity via
increased generation of reactive oxygen species and mPTP opening,
as found in other cellular contexts [20]. Pim-1may also act, in part, as anormal upstream regulator of Bcl-2 expression [29]. In a recent study
conducted on Pim-1 KO mice, the impossibility to induce cardiopro-
tection by different well known protective agents has been observed
[20]. Moreover, cardioprotective agents such as leukemia inhibitory
factor, insulin-like growth factor, dexamethasone and phorbol-12-
myristate-13-acetate induced Pim-1 immunoreactivity in neonatal rat
cardiomyocytes cultures. Importantly, Pim-1 induction by these
cardioprotective stimuli was detectable within 2 h after stimuli
application. We demonstrate that PostC avoids the Pim-1 reduction
that occurs in I/R. This result is in line with the expression of anti-
apoptotic Bcl-2 kinase. These results are also important considering
the fact that antagonists of kinases may not be highly speciﬁc. In
particular, the PI3K antagonist (LY29212) may interfere with Pim-1
activity [20,23]. Therefore, we cannot exclude that these inhibitors
also interfered with Pim-1, perhaps activated by different pathways
(i.e. JAK/STAT) during PostC treatments. In fact this pathway has been
proposed as an alternative to the RISK pathway in PostC [42].
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involved in the change of Pim-1 levels. In fact, PPA2 decreases Pim-1
protein levels [43], enhances I/R injury and limits cardioprotection
[44,45]. This hypothesis deserves future studies.
Here we show an enhanced phosphorylation/inactivation of GSK-
3β in mitochondria isolated from a PostC group (Fig 2), in agreement
with the reported increase in phosphorylation/inactivation of GSK-3β
in total samples [46]. This is an important point because GSK-3β
phosphorylation represents a pivotal step in the inhibition of mPTP
opening during the PostC protocol, as previously reported [7,33,41].
Although the role of GSK-3β phosphorylation in PostC has been
recently questioned [47], it is noteworthy that the pro-apoptotic
family Bcl-2-Bax is proposed as a novel target of GSK-3β downstream
to Akt in different cell lines [18,48].
An important release of cytochrome c occurs at the onset of
mitochondrial dysfunction [14]. In fact, in our study the cytochrome c
level was elevated only in I/R samples (Fig 2). In the Sham and PostC
samples the levels of this marker were lower; thus suggesting that
PostC treatments induce early salvage of the mitochondria in
reperfusion phase. In fact, antiapoptotic proteins (e.g., Bcl-2, Pim-1)
either directly compete with or impede proapoptotic factor activity,
stabilizing mitochondrial membranes and their channels thereby
preventing mitochondrial disruption [18].
It has been previously shown that the reduction of the level of
caspase-3 regulates mitochondrial events both in the initial and the
execution phases of apoptosis, such as Bax translocation and
cytochrome c release [49]. In the present study cleaved caspase-3
was signiﬁcantly elevated in the I/R group compared to the Sham and
PostC groups; thus suggesting that the PostC induced reduction of I/R
injury is in line with a reduced activation of pro-apoptotic kinases.
The analysis of a marker for mitochondrial integrity (i.e. HSP-60)
shows that the PostC protocol preserved mitochondria from I/R
damage. In fact PostC markedly limited the mitochondrial release of
this factor, which, actually, markedly increased in the cytosolic
fraction of I/R damaged myocardium. These results are conﬁrmed
by the conserved integrity of mitochondrial ultra-structure in PostC
hearts, as detected by electron microscopy analysis (Fig. 6).
Cx-43 is predominantly located in the sarcolemma, where six
connexins assemble into a so-called connexon or hemichannel [50].
Althoughmigration of Cx43 tomitochondria is controversial, it has also
been found in the inner mitochondrial membrane [12,48,51] where it
seems to play an important role in reactive oxygen species (ROS)
formation [12,13,52]. While Cx43-formed gap junctions are not
required for preconditioning protection [50], mitochondrial Cx43
may play an important role in preconditioning induced by ischemia or
by diazoxide, which require mitochondrial formation of ROS
[13,35,50,51]. Both protections are lost in Cx43 deﬁcient (Cx43+/−)
mice. In fact, cardiomyocytes of Cx43+/− mice have a speciﬁc
functional deﬁcit in ROS formation in response to diazoxide
[13,50,51]. Cx43 migrates via TOM/TIM-dependent mechanisms to
the mitochondria, where its phosphorylated component increases in
the inner mitochondrial membrane. It is likely that migration and
phosphorylation increase during preconditioning treatments and in
the reperfusion phase of index ischemia [33,50], when ROS formation
occurs. However, PostC protection is not lost in Cx43+/− mice
[12,13,50], thus suggesting that the increase in phospho-Cx43 mito-
chondrial component is not important in this protection. Here, we
conﬁrm that I/R increases the Cx43-phosphorylated mitochondrial
component, while reducing the cytosolic component. Yet, we show that
PostC limits the reduction of the total cytosolic fraction and limits the
increase in the phosphorylated mitochondrial component. It is likely
that this limited phosphorylation is not important [26,33,50–52], but
may contribute to the limited ROS production, which is, however,
necessary for PostC protection [1,6,41,53,54].
Mitochondrial Cx43 exists almost exclusively in the phosphory-
lated form [35,55,56, present study] indicating that phosphorylationcan play an important role in regulating mitochondrial Cx43 content.
However, it is not clear whether enhanced expression of phospho-
Cx43 in mitochondria by PostC is related to activation of RISKs
[26,35,50]. Finally, Heusch's Group studied the Cx43 phosphorylation
immediately after ischemia with and without ischemic precondition-
ing [26,51,52], but did not evaluate Cx43 phosphorylation after
ischemia and 2 h reperfusion. In this regard, our study and Heusch's
Group studies are not directly comparable.
The very rapid variation (within minutes) of cytoplasmatic and
mitochondrial protein content in response to ischemia/reperfusion
and postconditioning suggests that it is due to either changes in the
intracellular distribution, or enzymatic modiﬁcation (e.g. pro-caspase
3 cleavage) of proteins, rather than to increased protein synthesis.
Involvement of mitochondria in PostC is also consistent with the
observation that the protective effects of PostC can be mimicked by
mKATP openers and by mPTP blockers [41].
In conclusion, data suggest that mitochondrial protection and
anti-apoptotic effects are central aspects of PostC protection.
Protective kinases (i.e. Bcl-2, Pim-1 and phospho-GSK-3β) may play
a pivotal role in these protective mechanisms. In particular, we
report, for the ﬁrst time, the involvement of Pim-1 in PostC
cardioprotection, elucidating a new aspect of signaling with implica-
tions for the regulation of cell survival. The activation of these kinases
is accompanied by a reduction of pro-apoptotic elements (cyto-
chrome c and cleaved caspase-3) and preservation/modulation of
important components of the mitochondria (HSP-60 and pospho-
Cx43). Electron microscopy conﬁrmed that I/R induced marked
damages of cristae and mitochondrial membranes, which were
largely limited by PostC.
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